Titilayo Johnson

Dr. Titilayo Johnson


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
TJTitilayo Johnson
Titilayo Johnson
AAAbayomi Emmanuel Adegboyega
Abayomi Emmanuel Adegboyega
OOOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
AYAmina Jega Yusuf
Amina Jega Yusuf
OIOpeyemi Iwaloye
Opeyemi Iwaloye
CCCarlos Adam Conte-Junior
Carlos Adam Conte-Junior
The inhibitory potential of Artemisia annua, a well-known antimalarial herb, against several viruses, including the coronavirus, is increasingly gaining recognition. The plant extract has shown significant activity against both the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and the novel SARS-CoV-2 that is currently ravaging the world. It is therefore necessary to evaluate individual chemicals of the plant for inhibitory potential against SARS-CoV-2 for the purpose of designing drugs for the treatment of COVID-19. In this study, we employed computational techniques comprising molecular docking, binding free energy calculations, pharmacophore modeling, induced-fit docking, molecular dynamics simulation, and ADMET predictions to identify potential inhibitors of the SARS-CoV-2 main protease (Mpro) from 168 bioactive compounds of Artemisia annua. Rhamnocitrin, isokaempferide, kaempferol, quercimeritrin, apigenin, penduletin, isoquercitrin, astragalin, luteolin-7-glucoside, and isorhamnetin were ranked the highest, with docking scores ranging from −7.84 to −7.15 kcal/mol compared with the −6.59 kcal/mol demonstrated by the standard ligand. Rhamnocitrin, Isokaempferide, and kaempferol, like the standard ligand, interacted with important active site amino acid residues like HIS 41, CYS 145, ASN 142, and GLU 166, among others. Rhamnocitrin demonstrated good stability in the active site of the protein as there were no significant conformational changes during the simulation process. These compounds also possess acceptable druglike properties and a good safety profile. Hence, they could be considered for experimental studies and further development of drugs against COVID-19.

1 September 2021 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
TJTitilayo Johnson
Titilayo Johnson
AAAbayomi Emmanuel Adegboyega
Abayomi Emmanuel Adegboyega
OIOpeyemi Iwaloye
Opeyemi Iwaloye
OEOmokehinde Abiodun Eseola
Omokehinde Abiodun Eseola
WPWinfried Plass
Winfried Plass
OAOluyomi Stephen Adeyemi
Oluyomi Stephen Adeyemi
Owing to the urgent need for therapeutic interventions against the SARS-coronavirus 2 (SARS-CoV-2) pandemic, we employed an in silico approach to evaluate the SARS-CoV-2 inhibitory potential of newly synthesized imidazoles. The inhibitory potentials of the compounds against SARS-CoV-2 drug targets - main protease (Mpro), spike protein (Spro) and RNA-dependent RNA polymerase (RdRp) were investigated through molecular docking analysis. The binding free energy of the protein-ligand complexes were estimated, pharmacophore models were generated and the absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of the compounds were determined. The compounds displayed various levels of binding affinities for the SARS-CoV-2 drug targets. Bisimidazole C2 scored highest against all the targets, with its aromatic rings including the two imidazole groups contributing to the binding. Among the phenyl-substituted 1H-imidazoles, C9 scored highest against all targets. C11 scored highest against Spro and C12 against Mpro and RdRp among the thiophene-imidazoles. The compounds interacted with HIS 41 - CYS 145 and GLU 288 – ASP 289 – GLU 290 of Mpro, ASN 501 of Spro receptor binding motif and some active site amino acids of RdRp. These novel imidazole compounds could be further developed as drug candidates against SARS-CoV-2 following lead optimization and experimental studies.

22 November 2021 in Biochemistry and Biophysics Reports
Verified
Journal Article
Open access
TJTitilayo Johnson
Titilayo Johnson
Oluwafemi Adeleke OjoOluwafemi Adeleke Ojo
Oluwafemi Adeleke Ojo
SISoala Ikiriko
Soala Ikiriko
JOJesuseyifunmi Ogunkua
Jesuseyifunmi Ogunkua
GAGaius Olorunfemi Akinyemi
Gaius Olorunfemi Akinyemi
AAAbayomi Emmanuel Adegboyega
Abayomi Emmanuel Adegboyega
Acetylcholinesterase (AChE) has been an effective target for insecticide development which is a very important aspect of the global fight against insect-borne diseases. The drastic reduction in the sensitivity of insects to AChE-targeting insecticides like organophosphates and carbamates have increased the need for insecticides of natural origin. In this study, we used Drosophila melanogaster as a model to investigate the insecticidal and AChE inhibitory potentials of Cymbopogon citratus and its bioactive compounds. Flies were exposed to 100 and 200 mg/mL C. citratus leaf extract for a 3-h survival assay followed by 45 min exposure for negative geotaxis and biochemical assays. Molecular docking analysis of 45 bioactive compounds of the plant was conducted against Drosophila melanogaster AChE (DmAChE). Exposure to C. citratus significantly reduced the survival rate of flies throughout the exposure period and this was accompanied by a significant decrease in percentage negative geotaxis, AChE activity, catalase activity, total thiol level and a significant increase in glutathione-S-transferase (GST) activity. The bioactive compounds of C. citratus showed varying levels of binding affinities for the enzyme. (+)-Cymbodiacetal scored highest (−9.407 kcal/mol) followed by proximadiol (−8.253 kcal/mol), geranylacetone (−8.177 kcal/mol), and rutin (−8.148 kcal/mol). The four compounds occupied the same binding pocket and interacted with important active site amino acid residues as the co-crystallized ligand (1qon). These compounds could be responsible for the insecticidal and AChE inhibitory potentials of C. citratus and they could be further explored in the development of AChE-targeting insecticides.

1 May 2020 in Heliyon
Verified
Journal Article
Open access
TJTitilayo Johnson
Titilayo Johnson
KOKenneth Daniel Odoh
Kenneth Daniel Odoh
CNCharles Obiora Nwonuma
Charles Obiora Nwonuma
AAAugustina Oduje Akinsanmi
Augustina Oduje Akinsanmi
AAAbayomi Emmanuel Adegboyega
Abayomi Emmanuel Adegboyega
Ulcerative colitis (UC) is an inflammation of the colon that can progress to colorectal cancer if left untreated. No medication completely cures UC and natural products are sources of alternative approaches. This study aimed to determine the anti-inflammatory potential of Phyllanthus nivosus leaf extract and fractions in a rat model of ulcerative colitis and to identify the active ingredients. UC was induced in rats by intra-rectal infusion of 1ml of 4% acetic acid (AA) in normal saline. AA exposed groups of rats were treated with 100 mg/kg bodyweight of methanol extract, hexane, ethyl-acetate and butanol fractions orally for four days. Another group received the standard drug - Dexamethasone and control rats were given distilled water only. Some biochemical changes were evaluated and the active ingredients were identified using Gas Chromatography-Mass Spectrometry (GC-MS) followed by molecular docking against interleukin-1-beta converting enzyme (Caspase-1), beta-2 adrenergic receptor (ADRB2), cyclooxygenase-2 (COX-2) and tumour necrosis factor-alpha (TNF-α). Exposure of rat colon to acetic acid significantly altered (p < 0.05) serum levels of tumour necrosis factor-alpha (TNF-α), interleukin - 6 (IL-6), nitric oxide (NO), lipid peroxidation product (malondialdehyde or MDA), reduced glutathione (GSH); and activities of superoxide dismutase (SOD) and catalase (CAT). These alterations were however restored in the rats treated with P. nivosus leaf with the ethyl-acetate fraction displaying the highest ameliorative activity. GC-MS analysis of the ethyl acetate fraction revealed the presence of 40 compounds which when subjected to molecular docking demonstrated varying degrees of binding affinities for the protein targets. Ethyl iso-allocholate demonstrated the highest binding affinity for caspase-1, cholest-22-ene-21-ol, 3,5-dehydro-6- methoxy-, pivalate for ADRB2 and TNF-α; and alpha-cadinol for COX-2. The anti-inflammatory potential of Phyllanthus nivosus leaf as a natural remedy and as a source of new drugs against ulcerative colitis is validated.

1 January 2021 in Toxicology Reports
Verified
Journal Article
Open access
TJTitilayo Johnson
Titilayo Johnson
AAAmos Olalekan Abolaji
Amos Olalekan Abolaji
SOSimeon Omale
Simeon Omale
ILIshaya Yohanna Longdet
Ishaya Yohanna Longdet
RKRichard Joseph Kutshik
Richard Joseph Kutshik
ASAtiene Sagay
Atiene Sagay
• Canton-S strain of Drosophila melanogaster was investigated as a possible experimental model of Benzo[a]pyrene (B[a]P) toxicity. • B[a]P and its metabolite, BPDE, caused significant changes in negative geotaxis, fecundity and biochemical parameters of toxicity of the flies. • The compounds interacted with Drosophila glutathione-S-transferase (GST) and acetylcholinesterase (AChE) in a molecular docking analysis. • BPDE induced a high rate of mortality in this strain of flies possibly through AChE inhibition. • Canton-S strain of Drosophila melanogaster could be an alternative model to study B[a]P toxicity.

14 January 2023 in World Journal of Gastroenterology
Verified
Journal Article
Open access
TJTitilayo Johnson
Titilayo Johnson
AAAugustina Oduje Akinsanmi
Augustina Oduje Akinsanmi
SEStephen Adakole Ejembi
Stephen Adakole Ejembi
OAOlugbenga Eyitayo Adeyemi
Olugbenga Eyitayo Adeyemi
JOJane-Rose Oche
Jane-Rose Oche
AAAbayomi Emmanuel Adegboyega
Abayomi Emmanuel Adegboyega
Modern drug discovery for inflammatory bowel disease: The role of computational methods